Morningside Venture Investments Limited 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-04 4:19 pm Sale | 2023-09-25 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 2,313,227 3.430% | -2,305,619 (-49.92%) | Filing |
| 2023-08-17 5:15 pm Sale | 2023-08-15 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 4,618,846 6.860% | -4,000,000 (-46.41%) | Filing |
| 2023-04-03 4:43 pm Sale | 2023-03-29 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 8,618,846 12.920% | -683,296 (-7.35%) | Filing |
| 2022-09-30 4:05 pm Sale | 2022-09-23 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 9,302,142 15.890% | -1,376,666 (-12.89%) | Filing |
| 2022-01-25 4:54 pm Purchase | 2022-01-11 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 10,678,808 18.900% | 10,678,808 (New Position) | Filing |